Form 4: DocGo CEO Lee Bienstock Acquires 15,000 Shares of Common Stock
SEC Form 4 Filing
DocGo's CEO, Lee Bienstock, purchased 15,000 shares of the company's common stock at a price of $1.54 per share on May 14, 2025.
Summary
- On May 14, 2025, Lee Bienstock, the CEO of DocGo Inc. (DCGO), acquired 15,000 shares of common stock at $1.54 per share.
- Following this transaction, Bienstock directly owns 1,971,079 shares of DocGo's common stock.
- This amount includes various Restricted Stock Units (RSUs) that will vest over the next few years.
Sentiment
Score: 6
Explanation: Neutral to slightly positive sentiment. The CEO's purchase is a positive signal, but the document is primarily a regulatory filing.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often viewed positively by investors, as it can indicate management's belief in the company's future performance. However, it's important to consider the size of the purchase relative to the executive's overall holdings and the company's market capitalization.
Comparison to Industry Standards
- Comparing this transaction to other insider buys in the healthcare technology sector, the purchase of 15,000 shares is a moderate amount.
- For example, CEOs of similar-sized companies like Teladoc Health or Amwell have made larger purchases in the past, but this is dependent on individual financial circumstances and company-specific factors.
- It's also important to consider the vesting schedules of the RSUs, which are a common form of executive compensation in the industry.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive sign of confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| December 12, 2024 | First vesting date for 536,993 RSUs, with subsequent vesting annually for the next three years. |
| July 1, 2025 | Vesting date for 36,429 RSUs. |
| May 14, 2025 | Date of transaction: Lee Bienstock purchased 15,000 shares of common stock at $1.54 per share. |
| March 28, 2026 | Vesting date for 36,714 RSUs. |
| May 12, 2026 | First vesting date for 60,975 RSUs, with subsequent vesting annually. |
| May 12, 2027 | Second vesting date for 60,975 RSUs. |
| December 12, 2025 | Vesting date for 855,604 RSUs, with subsequent vesting annually for the next two years. |
| December 12, 2026 | Vesting date for 855,604 RSUs, with subsequent vesting annually. |
| December 12, 2027 | Final vesting date for 855,604 RSUs. |
Keywords
DocGo, Lee Bienstock, DCGO, Form 4, insider trading, common stock, RSUs, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.